Wednesday May 9 | Freshnews
AMAG Pharmaceuticals Appoints William Heiden as President and Chief Executive Officer
LEXINGTON, Mass. -- -- AMAG Pharmaceuticals, Inc. today announced the appointment of William K. Heiden as president and chief executive officer, effective May 14, 2012.
New life found at biotech farm in Charlton
Joann White production parlor supervisor at GTC Biotherapeutics' farm in Charlton prepares to milk a goat.
A&M goats modified to carry malaria vaccine
Texas A&M researcher Charles R. Long holds a female goat that is genetically modified to produce a malaria vaccine in it's milk at the The Reproductive Sciences Complex Tuesday, Jan.
TG Therapeutics Completes Licensing Agreement With LFB...
TG Therapeutics, Inc. - announced today an agreement with two LFB Group companies, LFB Biotechnologies S.A.S and GTC Biotherapeutics, Inc., to license the worldwide commercial rights to Ublituximab, a novel, third generation chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen found on B lymphocytes.